News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Q Therapeutics, Inc. Collaborates with Johns Hopkins University to Study Use of Neural Cells in Treatment of ALS


6/12/2008 10:23:42 AM

SALT LAKE CITY--(BUSINESS WIRE)--Q Therapeutics, Inc. announced today that it and Nicholas Maragakis, MD of Johns Hopkins University had received notification of an $800,000 grant to be awarded from the Maryland Stem Cell Research Fund (MSCRF) to enable study of Q’s human neural cell product Q-Cells® in preclinical models of Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s Disease). Nicholas Maragakis, MD, is an Associate Professor of Neurology at Johns Hopkins and is the Principal Investigator. James Campanelli, Ph.D., Senior Director of Research and Development at Q is Co-Investigator on the grant.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES